{
    "2019-11-08": [
        [
            {
                "time": "2018-11-15",
                "original_text": "Tilray (TLRY) Set to Report Q3 Results: Will the Stock Continue to Plunge?",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Q3 Results",
                        "Stock",
                        "Plunge"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Aduro (ADRO) Q3 Loss Wider Than Expected, Revenues Rise Y/Y",
                "features": {
                    "keywords": [
                        "Aduro",
                        "Q3 Loss",
                        "Revenues",
                        "Rise",
                        "Y/Y"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-08",
                "original_text": "Pharma Stock Roundup: AGN, NVO Q3 Earnings, FDA Nod to SNY & NVS' Products",
                "features": {
                    "keywords": [
                        "Pharma",
                        "AGN",
                        "NVO",
                        "Q3 Earnings",
                        "FDA",
                        "SNY",
                        "NVS",
                        "Products"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}